PRELUDE CAPITAL MANAGEMENT, LLC - DERMA SCIENCES INC ownership

DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 53 filers reported holding DERMA SCIENCES INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of DERMA SCIENCES INC
ValueSharesWeighting
Q4 2016$5,0000.0%1,0000.0%0.00%0.0%
Q3 2016$5,000
+150.0%
1,000
+150.0%
0.00%
Q2 2016$2,000
-93.1%
400
-88.2%
0.00%
-100.0%
Q1 2015$29,000
-14.7%
3,400
-8.1%
0.00%
-20.0%
Q4 2014$34,000
+78.9%
3,700
+60.9%
0.01%
+66.7%
Q3 2014$19,000
-92.1%
2,300
-88.5%
0.00%
-93.3%
Q1 2013$242,00020,0000.04%
Other shareholders
DERMA SCIENCES INC shareholders Q2 2016
NameSharesValueWeighting ↓
RA Capital Management 1,994,876$24,697,0002.58%
Broadfin Capital, LLC 771,598$9,552,0001.70%
Raging Capital Management, LLC 698,401$8,646,0001.49%
Camber Capital Management LP 950,000$11,761,0001.23%
DAFNA Capital Management LLC 57,009$706,0000.77%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 44,027$545,0000.67%
Baker Brothers Advisors 2,558,857$31,679,0000.45%
THB ASSET MANAGEMENT 430,810$5,333,0000.33%
EAM Investors, LLC 100,658$1,246,0000.25%
ROANOKE ASSET MANAGEMENT CORP/ NY 32,741$390,0000.19%
View complete list of DERMA SCIENCES INC shareholders